Association of serotonin transporter gene polymorphism with efficacy of the antidepressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders.

Syed GulfishanSumita HalderRajarshi KarShruti SrivastavaRachna Gupta

Published in: Human psychopharmacology (2022)

Identification of risk population can be carried out by genotype testing. Prior genotyping in MDD patients might help to predict a better clinical outcome with antidepressants.

Keyphrases

newly diagnosed
major depressive disorder
end stage renal disease
bipolar disorder
ejection fraction
chronic kidney disease
prognostic factors
gene expression
stress induced
drug induced
bioinformatics analysis